AstraZeneca says 92% vaccine effectiveness against Delta variant | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

AstraZeneca says 92% vaccine effectiveness against Delta variant

AstraZeneca said new data from Public Health England (PHE) demonstrated COVID-19 Vaccine AstraZeneca, offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian variant).

AstraZeneca vaccine is used in India as Covishield. Real world data from PHE, demonstrated two doses of COVID-19 Vaccine AstraZeneca are 92% effective against hospitalisation due to the Delta variant and showed no deaths among those vaccinated.

The vaccine also showed a high level of effectiveness against the Alpha variant (B.1.1.7; formerly the ‘Kent' variant) with an 86% reduction of hospitalisations and no deaths reported.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA